Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis - PubMed (original) (raw)

Review

Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis

Zhe Wang et al. BMC Cardiovasc Disord. 2018.

Abstract

Background: Vascular calcification is a risk factor for the pathogenesis of cardiovascular disease and mortality in dialysis patients. Nevertheless, the association between cardiac valve calcification (CVC) and the outcome of dialysis is still illusive. The purpose of this meta-analysis is to evaluate the association between theCVC and cardiovascular or all-cause mortality in dialysis patients.

Methods: Literatures involving the baseline CVC and cardiovascular or all-cause mortality in dialysis patients were searchedfrom the PubMed, Embase, as well as two Chinese databases (i.e. Wanfang and CNKI databases). Articles published before November 2016were eligible to the study.

Results: Ten studies involving 2686 participants were included. CVC was correlated with increased risk of cardiovascular mortality (hazard risk [HR]: 2.81; 95% confidence intervals [CI]: 1.92-4.10) and all-cause mortality (HR: 1.73; 95% CI: 1.42-2.11). Subgroup analysis showed an excess risk of all-cause mortality (HR: 1.35; 95% CI: 1.02-1.79) among patients with one CVC, and increased risk of all-cause mortality in patients with two CVCs (HR 2.15; 95% CI 1.57-2.94).

Conclusions: CVC is correlated with higher cardiovascular and all-cause mortality risk in dialysis patients. Regular follow-up monitoring of CVC may be helpful for risk stratification of patients underwent dialysis.

Keywords: Cardiac valve calcification; Chronic kidney disease; Dialysis; Meta-analysis; Mortality.

PubMed Disclaimer

Conflict of interest statement

Not applicable.

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1

Fig. 1

Flow chart of article selection

Fig. 2

Fig. 2

Association between CVC and all-cause mortality risk revealed by Forest plot

Fig. 3

Fig. 3

Association between CVC and cardiovascular mortality risk revealed by Forest plot

Fig. 4

Fig. 4

Evaluation of publication bias for all-cause mortality (a) andcardiovascular mortality (b)

References

    1. Bover J, Ureña-Torres P, Górriz JL, et al. Cardiovascular calcifications in chronic kidney disease: potential therapeutic implications. Nefrologia. 2016;36(6):597–608. doi: 10.1016/j.nefro.2016.05.023. - DOI - PubMed
    1. Karohl C, D'MarcoGascón L, Raggi P. Noninvasive imaging for assessment of calcification in chronic kidney disease[J] Nat Rev Nephrol. 2011;7(10):567–577. doi: 10.1038/nrneph.2011.110. - DOI - PubMed
    1. Yamada S, Giachelli CM. Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho. Bone. 2016 Nov;12 [Epub ahead of print] - PMC - PubMed
    1. Bellasi A, Ferramosca E, Ratti C, et al. Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients. J Nephrol. 2012;25(1):211–218. doi: 10.5301/JN.2011.8446. - DOI - PubMed
    1. Takahashi H, Ishii H, Aoyama T, et al. Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study. Am J Kidney Dis. 2013;61(2):254–261. doi: 10.1053/j.ajkd.2012.09.007. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources